ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Laura Mendonça Diefenthaeler, Julia Kasali Lima, Maria Carolina Buj, Giovani Gadonski, Matheus Gadonski Stortti Rosa, Alexandre Vieira, Gustavo Werutsky, Roberta Pozza, Juliana Giacomazzi
Brindha Senthil Kumar, Ponnagoundanpudur Sundaramoorthy Kirit, Nachimuthu Senthil Kumar, Shanmuganandam Sumathi, Samuel Lalhruaizela, Lal Hruaitluanga, Lal Hmingliana
Daniel F Pilco-Janeta, Myriam De la Cruz-Puebla, Daisy Guamán-Pilco, Diego Montenegro, Philipp Novotny, William Miranda
Eniola R Kadir, Kikelomo T Adesina, Olatunde Oyebanjo K Ibrahim, Beatrice O Owolabi, Olaniyi O Fatai, Tomilola M Olaseinde, Azeezat D Yakub, Hafsat A Ameen, Suleiman O Agodirin, Adegboyega A Fawole